CancerNetwork®
@CancerNetwrk
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
781 Following 30.2K Followers
Daraxonrasib has been approved for metastatic pancreatic cancer. We saw that coming. The RAS-agnostic indication? That was a bit of a surprise.
⬇️ We spoke with Nicholas Hornstein, MD, PhD (@GIMedOnc), about it!
#pancsm# #oncology# #cancer#
Show more
Blind Rank: GI cancer trials edition 🎯 @GIMedOnc ranks RASolute 302, BREAKWATER, MATTERHORN, MOUNTAINEER-03, and BESPOKE CRC — no notes, just gut instinct and expertise.
Do you agree with his order? 👇
Watch the full video here:
Show more
